查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1808835

数位生物製造市场，按生物製剂类型、按部署类型、按应用、按技术、按最终用户、按国家和地区划分 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Digital Biomanufacturing Market, By Biologic Type, By Deployment Type, By Application, By Technology, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 367 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年数位生物製造市场规模价值 212.3465 亿美元，2025 年至 2032 年的复合年增长率为 9.5%。

数位化生物製造是将人工智慧、机器学习、资料分析和自动化等数位技术融入生物生产流程。它能够提高生物製剂、疫苗以及细胞和基因疗法生产的效率、精确度和可扩展性。透过实现即时监控、预测性维护和流程优化，数位化生物製造能够提高产品品质、降低成本并加快开发进度，从而彻底改变生物技术和製药生产的未来。

数位生物製造市场-市场动态

生物製剂需求的不断增长预计将推动市场需求

生物製剂需求的不断增长正在加速製造业的数位转型。美国食品药物管理局 (FDA) 报告称，2023 年生物製剂占新药审批的 45% 以上。此外，政府对智慧製造的日益重视也推动了数位化生物製造的应用。然而，复杂的监管合规和高昂的资本投入是全球数位化生物製造市场发展的主要障碍。相反，人工智慧在製造业的扩张为市场成长提供了巨大的机会。此外，支持创新的公共资金也不断增加，包括数位基础设施和自动化领域。

数位生物製造市场—关键见解

根据我们的研究分析师的分析，预计全球市场在预测期内（2025-2032 年）的年复合成长率约为 9.5%。

根据生物製剂类型细分，预计抗体将在 2024 年占据最大市场份额

根据部署类型细分，本地部署是 2024 年的主要部署类型

根据应用细分，生物製造过程自动化是 2024 年的主要应用

根据技术细分，过程分析技术（PAT）是2024年的领先技术

根据最终用户细分，生物製药公司是 2024 年领先的最终用户

从地区来看，北美是 2024 年最大的收入来源

数位生物製造市场-細項分析：

全球数位生物製造市场根据生物类型、部署类型、应用、技术、最终用户和地区进行细分。

根据生物製剂类型，市场分为四类：抗体、疫苗、细胞和基因疗法以及其他。预计抗体领域将在预测期内占据主要市场份额。这是由于其在治疗癌症和自体免疫疾病等慢性疾病方面应用广泛，且产量高且对单株抗体的需求持续成长。

根据应用，市场可分为四大类：数位生物反应器规模化、远端设备监控、生物製造流程自动化及其他。生物製造过程自动化领域预计将占据主要市场份额。这种主导地位源自于对提高效率、减少人为错误和简化复杂生产流程的需求。

数位生物製造市场-地理洞察

在先进的生物技术基础设施、强大的政府资金以及人工智慧和自动化技术的早期采用的推动下，预计北美将在预测期内占据全球数位生物製造市场的主要市场份额。

另一方面，预计亚太地区将以最快的速度成长，这得益于生物製药製造中心的扩大、数位医疗技术投资的增加以及中国、印度和韩国等国家的政府支持措施。

数位生物製造市场-竞争格局：

对更快、更精准的生物製剂生产的需求日益增长，这推动了竞争，促使企业采用以数位整合、自动化和即时分析为中心的策略。企业正在投资智慧製造平台、人工智慧驱动的流程控制和数位孪生技术，以优化生产效率并缩短产品上市时间。与技术供应商的策略合作、基于云端的解决方案的扩展以及模组化生物生产系统的开发也日益受到关注，使企业能够提高灵活性、确保合规性，并在不断变化的行业格局中保持竞争优势。

最新动态：

2025 年 4 月，Sartorius Stedim Biotech 与 Tulip Interfaces 合作推出 Biobrain(R) Operate，这是一款无程式码数位套件，透过与 Sartorius 设备无缝整合来增强一次性生物处理，加速生物製药製造的数位转型。

目录

第一章：数位生物製造市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 按生物製剂类型分類的数位生物製造市场片段
    • 按部署类型分類的数位生物製造市场片段
    • 数位生物製造市场片段（按应用）
    • 数位生物製造市场技术片段
    • 最终用户的数位生物製造市场片段
    • 各国数位生物製造市场概况
    • 数位化生物製造市场（按地区）
  • 竞争洞察

第三章：数位化生物製造关键市场趋势

  • 数位生物製造市场驱动因素
    • 市场驱动因素的影响分析
  • 数位生物製造市场限制
    • 市场限制的影响分析
  • 数位生物製造市场机会
  • 数位生物製造市场未来趋势

第四章：数位化生物製造业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：数位生物製造市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：数位生物製造市场格局

  • 2024年数位生物製造市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：数位生物製造市场－依生物製剂类型

  • 概述
    • 按生物製剂类型分類的细分市场份额分析
    • 抗体
    • 疫苗
    • 细胞和基因疗法
    • 其他的

第 8 章：数位生物製造市场 - 按部署类型

  • 概述
    • 按部署类型分類的细分市场份额分析
    • 本地
    • 基于云端

第九章：数位生物製造市场－按应用

  • 概述
    • 按应用细分市场占有率分析
    • 数位生物反应器规模化
    • 远端设备监控
    • 生物製造流程自动化
    • 其他的

第 10 章：数位生物製造市场 - 按技术

  • 概述
    • 按技术细分的市场份额分析
    • 过程分析技术（PAT）
    • 製造执行系统（MES）
    • 数位孪生
    • 数据分析软体

第 11 章：数位生物製造市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 合约製造组织
    • 生物製药公司
    • 其他的

第 12 章：数位生物製造市场 - 按地理划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美数位生物製造主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（依生物製剂类型）
    • 北美市场规模和预测（按部署类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲数位生物製造主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（依生物製剂类型）
    • 欧洲市场规模及预测（按部署类型）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区数位生物製造主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依生物製剂类型）
    • 亚太地区市场规模及预测（依部署类型）
    • 亚太地区市场规模及预测（按应用）
    • 亚太地区市场规模及预测（依技术）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲数位生物製造主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依生物製剂类型）
    • 拉丁美洲市场规模及预测（按部署类型）
    • 拉丁美洲市场规模及预测（按应用）
    • 拉丁美洲市场规模及预测（按技术）
    • LATAM 规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲的数位生物製造关键製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按生物製剂类型）
    • 中东和非洲市场规模及预测（按部署类型）
    • 中东和非洲市场规模和预测（按应用）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 13 章：关键供应商分析-数位生物製造业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Atos SE
    • Danaher Corporation
    • Agilent Technologies Inc.
    • Donaldson Company, Inc.
    • General Electric Company
    • Emerson Electric Co.
    • Honeywell International Inc.
    • Siemens Healthineers AG
    • SAP SE
    • Bota Biosciences
    • e-matica srl
    • Culture Biosciences
    • Exponential Genomics, Inc.
    • OVO Biomanufacturing
    • FabricNano
    • Symphony Innovation, LLC
    • Ample Logic
    • Thermo Fisher Scientific
    • Bruker
    • ABB
    • Dassault Systems
    • Hamilton Company
    • Invert, Inc.
    • Eppendorf SE
    • Others

第 14 章：360 度分析师视角

第 15 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5499

Digital biomanufacturing market size was valued at US$ 21,234.65 Million in 2024, expanding at a CAGR of 9.5% from 2025 to 2032.

Digital biomanufacturing is the integration of digital technologies, such as artificial intelligence, machine learning, data analytics, and automation, into biological production processes. It enhances efficiency, precision, and scalability in the manufacturing of biologics, vaccines, and cell and gene therapies. By enabling real-time monitoring, predictive maintenance, and process optimization, digital biomanufacturing improves product quality, reduces costs, and accelerates development timelines, revolutionizing the future of biotechnology and pharmaceutical production.

Digital Biomanufacturing Market- Market Dynamics

Increasing demand for biologics is expected to propel the market demand

Rising demand for biologics is accelerating digital transformation in manufacturing, with the U.S. FDA reporting that biologics accounted for over 45% of new drug approvals in 2023. Besides, the growing government focus on smart manufacturing is driving the adoption of digital biomanufacturing. However, complex regulatory compliance and high capital investment are major barriers for the global digital biomanufacturing market. On the contrary, the expansion of AI in manufacturing presents a strong opportunity for market growth. Moreover, supportive public funding for innovation is growing, including digital infrastructure and automation.

Digital Biomanufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2025-2032)

Based on Biologic Type segmentation, antibodies were predicted to show maximum market share in the year 2024

Based on Deployment Type segmentation, on-premises was the leading Deployment Type in 2024

Based on Application segmentation, biomanufacturing process automation was the leading Application in 2024

Based on technology segmentation, process analytical technology (PAT) was the leading technology in 2024

Based on end user segmentation, biopharmaceutical companies were the leading end user in 2024

Based on region, North America was the leading revenue generator in 2024

Digital Biomanufacturing Market- Segmentation Analysis:

The Global Digital Biomanufacturing Market is segmented on the basis of Biologic Type, Deployment Type, Application, Technology, End User, and Region.

The market is divided into four categories based on Biologic Type: antibodies, vaccines, cell & gene therapies, and others. The antibodies segment is expected to hold the major market share during the forecast period. This is due to their widespread use in treating chronic diseases like cancer and autoimmune disorders, along with high production volumes and continuous demand for monoclonal antibodies.

The market is divided into four categories based on Application: digital bioreactor scaling, remote equipment monitoring, biomanufacturing process automation, and others. The biomanufacturing process automation segment is expected to hold the major market share. This dominance is driven by the need to enhance efficiency, reduce human error, and streamline complex production workflows.

Digital Biomanufacturing Market- Geographical Insights

North America is expected to hold the major market share in the global digital biomanufacturing market during the forecast period, driven by advanced biotechnology infrastructure, strong government funding, and early adoption of AI and automation technologies.

On the other hand, Asia-Pacific is projected to grow at the fastest rate, fueled by expanding biopharmaceutical manufacturing hubs, increasing investments in digital healthcare technologies, and supportive government initiatives in countries like China, India, and South Korea.

Digital Biomanufacturing Market- Competitive Landscape:

Growing demand for faster and more precise biologics production is driving competition, prompting companies to adopt strategies centered on digital integration, automation, and real-time analytics. Firms are investing in smart manufacturing platforms, AI-driven process control, and digital twins to optimize production efficiency and reduce time-to-market. Strategic collaborations with tech providers, expansion of cloud-based solutions, and development of modular bioproduction systems are also gaining traction, enabling players to enhance flexibility, ensure regulatory compliance, and maintain a competitive edge in an evolving industry landscape.

Recent Developments:

In April 2025, Sartorius Stedim Biotech partnered with Tulip Interfaces to launch Biobrain(R) Operate, a no-code digital suite enhancing single-use bioprocessing by integrating seamlessly with Sartorius equipment, accelerating digital transformation in biopharmaceutical manufacturing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIGITAL BIOMANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Atos SE
  • Danaher Corporation
  • Agilent Technologies Inc.
  • Donaldson Company, Inc.
  • General Electric Company
  • Emerson Electric Co.
  • Honeywell International Inc.
  • Siemens Healthineers AG
  • SAP SE
  • Bota Biosciences
  • e-matica srl
  • Culture Biosciences
  • Exponential Genomics, Inc.
  • OVO Biomanufacturing
  • FabricNano
  • Symphony Innovation, LLC
  • Ample Logic
  • Thermo Fisher Scientific
  • Bruker
  • ABB
  • Dassault Systems
  • Hamilton Company
  • Invert, Inc.
  • Eppendorf SE
  • Others

GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY BIOLOGIC TYPE- MARKET ANALYSIS, 2019 - 2032

  • Antibodies
  • Vaccines
  • Cell & Gene Therapies
  • Others

GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY DEPLOYMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • On-premises
  • Cloud-based

GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Digital Bioreactor Scaling
  • Remote Equipment Monitoring
  • Biomanufacturing Process Automation
  • Others

GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Process Analytical Technology (PAT)
  • Manufacturing Execution System (MES)
  • Digital Twins
  • Data Analytics Software

GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Contract Manufacturing Organizations
  • Biopharmaceutical Companies
  • Others

GLOBAL DIGITAL BIOMANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Digital Biomanufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Digital Biomanufacturing Market Snippet by Biologic Type
    • 2.1.2. Digital Biomanufacturing Market Snippet by Deployment Type
    • 2.1.3. Digital Biomanufacturing Market Snippet by Application
    • 2.1.4. Digital Biomanufacturing Market Snippet by Technology
    • 2.1.5. Digital Biomanufacturing Market Snippet by End User
    • 2.1.6. Digital Biomanufacturing Market Snippet by Country
    • 2.1.7. Digital Biomanufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. Digital Biomanufacturing Key Market Trends

  • 3.1. Digital Biomanufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Digital Biomanufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Digital Biomanufacturing Market Opportunities
  • 3.4. Digital Biomanufacturing Market Future Trends

4. Digital Biomanufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Digital Biomanufacturing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Digital Biomanufacturing Market Landscape

  • 6.1. Digital Biomanufacturing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Digital Biomanufacturing Market - By Biologic Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Biologic Type, 2024 & 2032 (%)
    • 7.1.2. Antibodies
    • 7.1.3. Vaccines
    • 7.1.4. Cell & Gene Therapies
    • 7.1.5. Others

8. Digital Biomanufacturing Market - By Deployment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Deployment Type, 2024 & 2032 (%)
    • 8.1.2. On-premises
    • 8.1.3. Cloud-based

9. Digital Biomanufacturing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Digital Bioreactor Scaling
    • 9.1.3. Remote Equipment Monitoring
    • 9.1.4. Biomanufacturing Process Automation
    • 9.1.5. Others

10. Digital Biomanufacturing Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 10.1.2. Process Analytical Technology (PAT)
    • 10.1.3. Manufacturing Execution System (MES)
    • 10.1.4. Digital Twins
    • 10.1.5. Data Analytics Software

11. Digital Biomanufacturing Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 11.1.2. Contract Manufacturing Organizations
    • 11.1.3. Biopharmaceutical Companies
    • 11.1.4. Others

12. Digital Biomanufacturing Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Digital Biomanufacturing Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Digital Biomanufacturing Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Digital Biomanufacturing Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Digital Biomanufacturing Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Digital Biomanufacturing Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Biologic Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Deployment Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Digital Biomanufacturing Industry

  • 13.1. Competitive Dashboard
    • 13.1.1. Competitive Benchmarking
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Atos SE
    • 13.2.2. Danaher Corporation
    • 13.2.3. Agilent Technologies Inc.
    • 13.2.4. Donaldson Company, Inc.
    • 13.2.5. General Electric Company
    • 13.2.6. Emerson Electric Co.
    • 13.2.7. Honeywell International Inc.
    • 13.2.8. Siemens Healthineers AG
    • 13.2.9. SAP SE
    • 13.2.10. Bota Biosciences
    • 13.2.11. e-matica srl
    • 13.2.12. Culture Biosciences
    • 13.2.13. Exponential Genomics, Inc.
    • 13.2.14. OVO Biomanufacturing
    • 13.2.15. FabricNano
    • 13.2.16. Symphony Innovation, LLC
    • 13.2.17. Ample Logic
    • 13.2.18. Thermo Fisher Scientific
    • 13.2.19. Bruker
    • 13.2.20. ABB
    • 13.2.21. Dassault Systems
    • 13.2.22. Hamilton Company
    • 13.2.23. Invert, Inc.
    • 13.2.24. Eppendorf SE
    • 13.2.25. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us